ONPH — Oncology Pharma Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.61m
- $0.01m
Annual balance sheet for Oncology Pharma, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2002 March 31st | 2003 March 31st | 2004 March 31st | 2011 June 30th | 2013 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10KSB | 10KSB | 10KSB | PRESS | ARS |
Standards: | USG | USG | USG | — | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 2.93 | 1.35 | 0.008 | — | 0.009 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.061 | 0.171 | 0.019 | 0.015 | 0 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.1 | 1.58 | 0.048 | 0.165 | 0.187 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.503 | 0.129 | 0 | 0.062 | 0.006 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 3.61 | 1.75 | 0.048 | 0.262 | 0.199 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.24 | 0.879 | 0.22 | 0.666 | 0.213 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.24 | 0.879 | 0.22 | 0.666 | 0.419 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2.37 | 0.872 | -0.172 | -0.404 | -0.22 |
Total Liabilities & Shareholders' Equity | 3.61 | 1.75 | 0.048 | 0.262 | 0.199 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |